Nikko Asset Management Americas’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-74,909
Closed -$6.94M 155
2018
Q2
$6.94M Buy
74,909
+63,405
+551% +$6.19M 0.21% 86
2018
Q1
$1.09M Buy
+11,504
New +$1.26M 0.04% 131
2017
Q4
Sell
-7,800
Closed -$693K 262
2017
Q3
$693K Sell
7,800
-81,200
-91% -$6.18M 0.03% 154
2017
Q2
$6.45M Buy
89,000
+13,900
+19% +$934K 0.38% 89
2017
Q1
$4.89M Buy
75,100
+40,500
+117% +$2.55M 0.36% 68
2016
Q4
$2.17M Sell
34,600
-20,000
-37% -$1.22M 0.17% 82
2016
Q3
$3.44M Buy
54,600
+18,200
+50% +$1.18M 0.29% 70
2016
Q2
$2.25M Buy
36,400
+10,400
+40% +$634K 0.21% 79
2016
Q1
$1.48M Sell
26,000
-100
-0.4% -$5.57K 0.18% 84
2015
Q4
$1.56M Buy
26,100
+1,900
+8% +$109K 0.18% 90
2015
Q3
$1.28M Sell
24,200
-3,700
-13% -$241K 0.13% 93
2015
Q2
$1.87M Buy
27,900
+100
+0.4% +$6.53K 0.13% 93
2015
Q1
$1.62M Buy
27,800
+5,500
+25% +$332K 0.13% 93
2014
Q4
$1.48M Buy
22,300
+500
+2% +$31.5K 0.11% 99
2014
Q3
$1.28M Buy
21,800
+8,300
+61% +$461K 0.08% 99
2014
Q2
$767K Sell
13,500
-5,300
-28% -$278K 0.04% 120
2014
Q1
$959K Buy
18,800
+8,300
+79% +$419K 0.04% 107
2013
Q4
$556K Buy
+10,500
New +$516K 0.02% 126

Other funds holding ABBV

Nikko Asset Management Americas's ABBV Position: Q3 2018 in Review

Nikko Asset Management Americas sold out of AbbVie (ABBV) in Q3 2018, closing a stake of 74,909 shares — an estimated $6.94M sold.

Nikko Asset Management Americas first reported a position in ABBV in Q4 2013 and held it in 18 quarters. The position peaked at $6.94M in Q2 2018. 1,956 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

  • Nikko Asset Management Americas reported no remaining AbbVie position as of Q3 2018 after selling out during the quarter.
  • Nikko Asset Management Americas sold 74,909 AbbVie shares in Q3 2018, an estimated $6.94M.
  • Nikko Asset Management Americas first reported a position in AbbVie in Q4 2013 and held it in 18 quarters.
  • Nikko Asset Management Americas's AbbVie position peaked at $6.94M in Q2 2018.
  • 1,956 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Nikko Asset Management Americas's 13F filing for Q3 2018, filed 15 Oct 2018.